ClinicalTrials.gg
RecruitingNCT07331298CADDIEUpdated Jun 26, 2026

Apparent Diffusion Coefficient of the Intervertebral Disc in Children: Pilot Study

An observational study in Scoliosis Idiopathic, sponsored by University Hospital, Limoges. Recruiting at 2 sites in France. Open to participants aged 8 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-06-26.

Sponsored by University Hospital, Limoges · Observational

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
60
Ages
8 Years to 16 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Scoliosis with a site in France — 18 open to participants now, 20 under way, 1 of them phase 3. Scoliosis · France.

Planned enrollment
19th of 32
60 · median 84
Started
2026
with 6 others
Observational
32 of 57
6 open now
Primary completion
2028-04
later than 16 of 19 live
Registered
47th of 57
by date

Among the 57 studies in Scoliosis with a site in France, this one is the 19th largest by planned enrollment of the 32 observational ones that give a count, is one of 7 that started in 2026, is one of 32 observational ones, reaches primary completion later than 16 of the 19 other live ones, and was the 47th registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

Browse Scoliosis studies →

Open to participants now

18 of the 57 studies in Scoliosis with a site in France are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 8 Years to 16 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Scoliosis with a site in France, or all of them as a file.
02

Study summary

The pathophysiology of adolescent idiopathic scoliosis is unknown. This pathology develops from 10-11 years of age and progresses until skeletal maturity, or even adulthood for the most severe forms.

Current knowledge is limited as to its origin on the one hand and the evolutionary nature of scoliosis on the other.

The mechanical parameters of the intervertebral disc are incompletely known from the deep location of this organ, its fragile nature in vivo and its susceptibility to desiccation during ex-vivo analysis.

To complete our knowledge of the mechanical parameters of the intervertebral disc of scoliotic and non-scoliotic children, we are proposing an in vivo, non-invasive and non-irradiating study carried out in children who are the main target of this pathology.

The objective of this work is to characterize the diffusion parameters (apparent diffusion coefficient ADC) of the intervertebral disc in vivo, in a non-invasive and non-irradiating manner by magnetic resonance imaging in children and adolescents. As this measurement has not been carried out in children and adolescents, we want to perform these MRI scans in children free from scoliosis and carriers of scoliosis.

03

Conditions studied

  • Scoliosis Idiopathic

Browse trials for

Keywords

  • apparent diffusion coeficient
  • intervertebral disc
  • scoliosis
  • child
04

Who can participate

Ages eligible
8 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

children and adolescents with and without scoliosis seen in consultation and requiring magnetic resonance imaging of the lumbar region

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age: patients between 8 and 16 years old
  • Children undergoing magnetic resonance imaging of the lumbar or spinal region as part of their routine care
  • Scoliotic: spinal deformity characterized by a hump on clinical examination and a radiological deformation in the coronal plane greater than 10 ° with no etiology found (idiopathic)
  • Healthy: no hump on clinical examination, walking patients (level 1 and 2 of the global motor function classification system)

Exclusion criteria

Exclusion Criteria:

  • existence of medullary and vertebral pathology other than scoliosis, history of disc or vertebral infection (spondylo-discitis) on examination, neuro-ectodermal pathology
  • behavioral disturbances incompatible with the performance of the magnetic resonance imaging examination.
  • Refusal of participation.
  • Thoracic scoliosis
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
60 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes

Groups and cohorts

  • Scoliotic patients

    children with spinal deformity characterized by a hump on clinical examination and a radiological deformation in the coronal plane greater than 10 ° .

    Other: magnetic resonance imaging of the lumbar or spinal region

  • Non scoliotic patients

    Childrne with no hump on clinical examination, able to walk.

    Other: magnetic resonance imaging of the lumbar or spinal region

Interventions

  • Othermagnetic resonance imaging of the lumbar or spinal region

    The duration of the acquisition sequence between 2 and 10 minutes additional compared to a conventional magnetic resonance imaging examination.

06

What researchers measure

Primary outcomes

  1. measurement of the value of Apparent Diffusion Coefficient (ADC) in magnetic resonance imaging.

    Time frame: between Day 15 and Day 90

Secondary outcomes

  1. Apparent Diffusion Coefficient difference for scoliosis and non-scoliosis patients for one level

    Time frame: between Day 15 and Day 90

  2. Correlation between right and left Apparent Diffusion Coefficient and inclination of two vertebra for scoliosis patients

    Time frame: between Day 15 and Day 90

  3. gagCEST(Chemical Exchange Saturation Transfer) measurement in magnetic resonance imaging of the discs

    Time frame: between Day 15 and Day 90

07

Study locations

1 of 2 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Apr 2028, 26 months after the start.

Of 94 non-industry observational studies under Scoliosis, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 99. This study's planned 26 months is below that.

Counting every sponsor, half of 106 studies reached it within 36 months; a quarter within 9 and three quarters within 92.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2025
First posted
Jan 9, 2026
StartActual
Jan 5, 2026
Primary completionEst.
Apr 1, 2028
CompletionEst.
Apr 1, 2028
Last update
Jun 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07331298
Responsible party
Sponsor
First posted
Jan 9, 2026
Start date
Jan 5, 2026
Primary completion
Apr 1, 2028 (estimated)
Completion
Apr 1, 2028 (estimated)
Last update
Jun 26, 2026

Study contacts

Quentin BALLOUHEY, MD
Contact
quentin.ballouhey@chu-limoges.fr
+33555052410
Edouard LOEVENBRUCK
Contact
Edouard.LOEVENBRUCK@chu-limoges.fr

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion